GTCHOTCServices-Management Consulting ServicesUS GAAP · USD

GBT Technologies Inc.

GBT Technologies Inc. is a Nevada-based microcap company that combines IT consulting, technology licensing, and selective commercialization of internally developed IP. Its reported activities center on IoT and AI-enabled networking, asset tracking, an intelligent human vitals device, and patent-driven technologies that it seeks to monetize through licensing, joint ventures, and occasional asset sales.

Operating profit (EBIT)-0.6m USD
+63.0 %y/y
Net income20.7m USD
+216.6 %y/y
Free cash flow0.0m USD
+152.9 %y/y

Fiscal year 2024 · change from previous year

Development 2019–2024

-200-150-100-50050m USD2019: 19 m USD2019: EBIT -176 m USD20192020: EBIT -7.8 m USD20202021: 0.18 m USD2021: EBIT -18 m USD20212022: 0.09 m USD2022: EBIT -2.8 m USD20222023: 0.09 m USD2023: EBIT -1.7 m USD20232024: EBIT -0.64 m USD2024-0.64
RevenueOperating profit (EBIT)

Business

Share of revenue
IT consulting services35 %

Consulting and related professional services provided to external clients.

Technology licensing30 %

Licensing of internally developed technology and code sources to third parties.

IoT and AI technology development20 %

Development of IoT, AI-enabled networking, tracking, and mesh network technologies.

E-commerce electronics sales0 %

Legacy online sales of electronic products, terminated in July 2023.

Patent and IP transactions15 %

Patent purchases, sales, and joint venture-related IP commercialization activities.

Customers

GBT serves a mix of consulting clients, technology licensees, and counterparties interested in acquiring or commercializing its IP. The company also has historical exposure to e-commerce buyers through an online retail platform, but that activity was terminated in 2023. Its customer base is therefore fragmented and transaction-driven rather than anchored in recurring enterprise contracts.

IT consulting clients

Buy professional IT services for implementation, support, or advisory work.

Technology licensees

Acquire rights to use GBT-developed technologies or code sources.

IP buyers and strategic acquirers

Purchase patents or technology assets, such as the VisionWave transaction.

Joint venture partners

Partner to develop and commercialize technologies through structured agreements.

E-commerce buyers

Historical online retail customers for electronic products before the business was terminated.

Strategy

GBT’s strategy is to commercialize its technology portfolio through licensing, joint ventures, and selective asset sales rather than relying only on consulting revenue. The company is focused on IoT, AI-enabled networking, tracking, and sensor-related technologies that it believes can be monetized through patents, code sources, and product development. Preserving liquidity and finding external partners are central because the business remains early-stage and capital constrained.

Commercialize the technology portfolioShort term

Licensing and IP sales are the clearest path to monetization for a small company with limited operating scale.

Advance IoT and AI-enabled product developmentMedium term

Productization can create higher-value recurring opportunities than one-off consulting work.

Use partnerships and joint venturesMedium term

External partners can provide capital, commercialization channels, and technical validation.

Geography

GBT is incorporated in Nevada and appears to operate with a U.S.-centered commercial footprint, while some of its technology and holding activities are structured through foreign subsidiaries such as Greenwich International Holdings in Costa Rica. The company also references counterparties in Argentina and other cross-border arrangements, indicating that commercialization and IP transactions can extend beyond the United States. No authoritative country revenue split was disclosed in the provided excerpts.

Risks

GBT faces the risks typical of an early-stage microcap technology company: limited operating history, uncertain product-market fit, and dependence on outside capital. Its disclosures also highlight weak internal controls, reliance on key personnel, and OTC-market trading risks that can amplify volatility and reduce liquidity. Because the business is still trying to convert IP into revenue, execution and financing risk remain central.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Limited operating history and unproven business model1Capital constraints and going-concern pressure2Internal control weaknesses3Key personnel dependence4OTC market liquidity and volatility5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Limited operating history and unproven business modelImpact: HighLikelihood: High

    The company is still building a repeatable revenue base, so future demand and margins are uncertain.

    Exposure: Technology commercialization and consulting operations

  2. Capital constraints and going-concern pressureImpact: HighLikelihood: High

    Management states the business requires substantial capital and may need to curtail operations if funding is unavailable.

    Exposure: Liquidity and operating continuity

  3. Internal control weaknessesImpact: HighLikelihood: Medium

    The company disclosed ineffective disclosure controls in prior periods due to limited resources and reliance on outside consultants.

    Exposure: Financial reporting reliability

  4. Key personnel dependenceImpact: MediumLikelihood: High

    A small organization may struggle to attract and retain the technical and managerial talent needed to execute.

    Exposure: Product development and commercialization

  5. OTC market liquidity and volatilityImpact: MediumLikelihood: High

    Thin trading and speculative stock characteristics can limit investor liquidity and increase price swings.

    Exposure: Common stock trading

Accounting

Judgemental items
Revenue recognition

Consulting, licensing, and patent transactions may recognize revenue at different points in time.

Impact: Can create quarter-to-quarter volatility and affect comparability.

Development cost expensing

The company states it does not capitalize development costs, so R&D-like spending flows directly through earnings.

Impact: Increases reported losses during product development phases.

Asset sale and IP transaction accounting

Patent purchases and technology sales can generate non-recurring gains or losses.

Impact: May distort underlying operating performance.

Internal control and estimate judgments

Prior disclosure control weaknesses increase the risk of misstatement in small-company reporting.

Impact: Affects reliability of reported results and investor confidence.

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026